lymphoma

Latest stories

  • in Health care

    USFDA nod to Roche’s Polivy in combination with R-CHP for certain types of previously untreated diffuse large B-cell lymphoma

    by

    Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab), cyclophosphamide, doxorubicin and prednisone (R-CHP) for the treatment of adult patients who have previously untreated diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS) or high-grade B-cell lymphoma (HGBL) and who have an […] More

  • in Health care

    Human non-hodgkin lymphoma cured by novel nuclear medicine therapy in preclinical model

    Human non-hodgkin lymphoma cured by novel nuclear medicine therapy in preclinical model

    by

    Non-Hodgkin lymphoma is a common blood malignancy. The American Cancer Society estimates that more than 80,500 new cases and 20,100 deaths will occur in the United States in 2023. The standard of care for many non-Hodgkin lymphoma patients involves chemotherapy and immunotherapy targeting the CD20 protein, which is highly expressed on most non-Hodgkin lymphoma cells. […] More